[144] Oric Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

Oric Pharmaceuticals, Inc. notice reports a proposed sale of 250,000 common shares through J.P. Morgan Securities LLC on 09/22/2025 with an aggregate market value of $2,625,000. The issuer has 97,122,987 shares outstanding, making the offered amount a small fraction of total shares. The filer states the 250,000 shares were acquired in an open market purchase on 05/11/2022 and were paid for in cash. The filing reports no securities sold in the past three months and includes the seller's certification regarding absence of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small, routine insider sale of 250,000 shares, not likely material to ORIC's market cap.

This Form 144 notifies the market of a planned brokered sale of 250,000 common shares via J.P. Morgan Securities LLC at an aggregate market value of $2,625,000. Relative to the 97,122,987 shares outstanding, the sale represents roughly 0.26% of the float, indicating limited direct dilution or supply shock. The shares were acquired in the open market on 05/11/2022 and paid in cash, consistent with routine liquidity actions rather than corporate actions. Absent additional context or large aggregated sales, this filing appears informational and non-material to valuation.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure; the filing documents a permitted sale and includes required seller certifications.

The Form 144 contains standard disclosures required under Rule 144: identity of broker, share count, acquisition date and method, and a representation about undisclosed material information. The absence of reported sales in the prior three months simplifies aggregation concerns. From a governance standpoint, the filing demonstrates procedural compliance with public disclosure obligations but does not indicate changes in ownership control or management position.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 390 Madison Avenue 6th Floor New York NY 10017	250000	2625000	97122987	09/22/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/11/2022	Open Market Purchase	See Nature of Acquisition			250000	05/11/2022	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ORIC's Form 144 disclose about the size of the proposed sale?

The filing discloses a proposed sale of 250,000 common shares with an aggregate market value of $2,625,000.

When is the ORIC share sale expected to occur according to the filing?

The approximate date of sale listed in the filing is 09/22/2025.

Who is the broker handling the ORIC sale in the Form 144?

The broker named is J.P. Morgan Securities LLC at 390 Madison Avenue, New York, NY.

How and when were the shares being sold originally acquired?

The 250,000 shares were acquired in an open market purchase on 05/11/2022, paid in cash.

Does the filing report any other sales by the seller in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.